Kay Kay Health Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.00 M
- Company Age 4 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.00 M
- Revenue Growth -57.58%
- Profit Growth -174.34%
- Ebitda -199.06%
- Net Worth -43.15%
- Total Assets 97.08%
About Kay Kay Health Sciences
Kay Kay Health Sciences Private Limited (KKHSPL) is a Private Limited Indian Non-Government Company incorporated in India on 23 September 2020 (Four years and five months 3 days old ). Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Consumer Goods Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹9.00 M.
Balakrishnan Amarnath and Suresh Kataria serve as directors at the Company.
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51909TN2020PTC138152
- Company No.
138152
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Sep 2020
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Kay Kay Health Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Balakrishnan Amarnath  | Director | 23-Sep-2020 | Current |
| Suresh Kataria | Director | 28-Oct-2021 | Current |
Financial Performance of Kay Kay Health Sciences.
Kay Kay Health Sciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 57.58% decrease. The company also saw a substantial fall in profitability, with a 174.34% decrease in profit. The company's net worth observed a substantial decline by a decrease of 43.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kay Kay Health Sciences?
Unlock access to Kay Kay Health Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹9.00 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.90 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Dec 2021 | State Bank Of India | ₹9.00 M | Open |
How Many Employees Work at Kay Kay Health Sciences?
Kay Kay Health Sciences has a workforce of 0 employees as of Mar 21, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kay Kay Health Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kay Kay Health Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
